PWAM
RIGL icon

Private Wealth Asset Management’s Rigel Pharmaceuticals RIGL Stock Holding History

Private Wealth Asset Management’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.6K Sell
400
-300
-43% -$9.25K ﹤0.01% 620
2026
Q1 		$18.9K Buy
700
+400
+133% +$13.4K ﹤0.01% 574
2025
Q4 		$12.8K Hold
300
– – ﹤0.01% 625
2025
Q3 		$8.5K Buy
+300
New +$8.97K ﹤0.01% 676

Other funds holding RIGL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Private Wealth Asset Management's RIGL Position: Q2 2026 in Review

Private Wealth Asset Management reduced its Rigel Pharmaceuticals (RIGL) stake by 43% in Q2 2026, selling an estimated $9.25K and leaving 400 shares worth $15.6K. The position accounts for ﹤0.01% of the portfolio, ranked #620.

Private Wealth Asset Management first reported a position in RIGL in Q3 2025 and has held it in 4 quarters since. The position peaked at $18.9K in Q1 2026. 156 funds tracked by Wall St. Rank hold RIGL as of Q2 2026.

  • Private Wealth Asset Management held 400 shares of Rigel Pharmaceuticals worth $15.6K as of Q2 2026.
  • Private Wealth Asset Management sold 300 Rigel Pharmaceuticals shares in Q2 2026, an estimated $9.25K.
  • Rigel Pharmaceuticals made up ﹤0.01% of Private Wealth Asset Management's portfolio in Q2 2026, its #620 holding.
  • Private Wealth Asset Management first reported a position in Rigel Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • Private Wealth Asset Management's Rigel Pharmaceuticals position peaked at $18.9K in Q1 2026.
  • 156 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q2 2026.

Based on Private Wealth Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.